Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 816.50 | 794.79 | 1.0265 | 1.0363 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 983.67 | 794.79 | 1.2403 | 1.3608 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 917.50 | 794.79 | 1.1580 | 1.2408 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 855.00 | 794.79 | 1.0741 | 1.1068 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 813.17 | 794.79 | 1.0218 | 1.0303 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 733.50 | 794.79 | 0.9223 | 0.8760 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 615.33 | 794.79 | 0.7739 | 0.6379 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 747.17 | 794.79 | 0.9404 | 0.9035 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1890.83 | 1766.52 | 1.0695 | 1.0990 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1859.83 | 1766.52 | 1.0551 | 1.0803 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2026.67 | 1766.52 | 1.1481 | 1.2137 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1925.50 | 1766.52 | 1.0896 | 1.1284 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1797.50 | 1766.52 | 1.0171 | 1.0214 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1656.50 | 1766.52 | 0.9381 | 0.9080 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1603.17 | 1766.52 | 0.9070 | 0.8600 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1207.83 | 1766.52 | 0.6843 | 0.5151 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1176.33 | 1766.52 | 0.6654 | 0.4794 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4038.17 | 4087.92 | 0.9886 | 0.9847 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3913.33 | 4087.92 | 0.9610 | 0.9492 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4370.17 | 4087.92 | 1.0691 | 1.0908 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4153.33 | 4087.92 | 1.0136 | 1.0141 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3635.83 | 4087.92 | 0.8878 | 0.8452 |
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3444.33 | 4087.92 | 0.8402 | 0.7775 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3170.33 | 4087.92 | 0.7762 | 0.6902 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2566.83 | 4087.92 | 0.6248 | 0.4582 |